Theravance Biopharma shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Theravance Biopharma by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $204k | 22k | 9.41 |
2024-09-30 | $137k | 17k | 8.06 |
2024-06-30 | $138k | 16k | 8.48 |
2024-03-31 | $160k | 18k | 8.97 |
2023-12-31 | $186k | 17k | 11.24 |
2023-09-30 | $129k | 15k | 8.64 |
2023-06-30 | $253k | 24k | 10.35 |
2022-12-31 | $12k | 1.0k | 11.21 |
2022-09-30 | $20k | 2.0k | 9.81 |
2022-06-30 | $25k | 2.6k | 9.58 |
2022-03-31 | $71k | 7.4k | 9.51 |
2021-12-31 | $333k | 30k | 11.07 |
2021-09-30 | $113k | 16k | 7.33 |
2021-06-30 | $2.8M | 189k | 14.71 |
2021-03-31 | $3.7M | 183k | 20.41 |
2020-12-31 | $4.8M | 272k | 17.77 |
2020-09-30 | $4.1M | 277k | 14.79 |
2020-06-30 | $5.9M | 281k | 20.99 |
2020-03-31 | $4.6M | 200k | 23.11 |
2019-12-31 | $5.1M | 197k | 25.89 |
2019-09-30 | $3.0M | 155k | 19.48 |
2019-06-30 | $2.4M | 147k | 16.33 |
2019-03-31 | $3.4M | 150k | 22.67 |
2018-12-31 | $3.4M | 132k | 25.59 |
2018-09-30 | $4.2M | 129k | 32.67 |
2018-06-30 | $2.9M | 128k | 22.68 |
2018-03-31 | $3.3M | 137k | 24.25 |
2017-12-31 | $3.8M | 135k | 27.89 |
2017-06-30 | $3.5M | 89k | 39.85 |
2017-03-31 | $1.2M | 32k | 36.82 |
2016-12-31 | $930k | 29k | 31.89 |
2016-09-30 | $465k | 13k | 36.23 |
2016-06-30 | $280k | 12k | 22.70 |
2016-03-31 | $172k | 9.1k | 18.86 |
2015-12-31 | $144k | 8.8k | 16.34 |
2015-09-30 | $79k | 7.2k | 11.00 |
2015-03-31 | $144k | 7.3k | 19.61 |
2014-12-31 | $96k | 6.6k | 14.58 |
2014-06-30 | $321k | 10k | 31.74 |